The FLOW study particularly indicated that semaglutide decreased the progression to end-stage renal disease by 24% in individuals with diabetic kidney disease (Rossing et al
There is also no strong evidence showing how it might affect a breastfed baby if it does
Pew Research Center reported Ozempic, Rybisus, and Waygovy had a combined sales of $21.1 billion for Novo Nordisk, a company that produces them, in 2024.
Get started on your Mito Health membership today
If youre near Maitland and have a BMI of 30 or above, or a BMI of 27 with weight-related health conditions, Semaglutide might be a viable option for you
Verrotti A, Trotta D, Morgese G, Chiarelli F: Valproate-induced hyperammonemic encephalopathy